{
    "balance": {
      "quarter": "Q1 25",
      "price": 6.15,
      "mc": 52,
      "cash": 70,
      "debt": 179,
      "ev": 161,
      "shares": 8.6,
      "aPIC": 1381,
      "ad": 1586,
      "FCF": -39,
      "runway": -1.795,
      "institutional": 0.44,
      "note": "1.8 quartal oder 5 monate bis zum bankrott wenn keine kapitalerh√∂hung passiert"
    },
    "fundamentals": {
      "2024": {
        "rev": 145,
        "cogs": 6,
        "sga": 115,
        "rnd": 143,
        "net_loss": 76,
        "shares": 8.4
      },
      "2023": {
        "rev": 146,
        "cogs": 5,
        "sga": 131,
        "rnd": 138,
        "net_loss": 143,
        "shares": 114
      }
    },
    "pipeline": [
      {
        "drug": "xpovio",
        "phase": "fda approved",
        "indication": "blood cancer"
      },
      {
        "drug": "selinexor",
        "phase": "3",
        "indication": "gebarmutterhalscar",
        "catalyst": "2h 25",
        "result": "topline"
      }
    ],
    "other": {
      "event": "1:12 reverse stock split"
    }
  }
  